No Data
No Data
Evaluating Harmony Biosciences: Insights From 8 Financial Analysts
Harmony Biosciences (NASDAQ:HRMY) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below offers a condensed view of their rece
HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the upco
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Astria Therapeutics (ATXS)
Harmony Biosciences Holdings Insider Sold Shares Worth $383,328, According to a Recent SEC Filing
Jeffrey Dierks, CHIEF COMMERCIAL OFFICER, on March 15, 2024, sold 11,979 shares in Harmony Biosciences Holdings (HRMY) for $383,328. SEC Filing: https://www.sec.gov/Archives/edgar/data/1802665/0001415
Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares
Harmony Biosciences(HRMY.US) Officer Sells US$383.33K in Common Stocks
$Harmony Biosciences(HRMY.US)$ Officer Dierks Jeffrey sold 11,979 shares of Common Stocks on Mar 15, 2024 at an average price of $32 for a total value of $383.33K.Source: Announcement What is statemen
No Data